The Washington Post @washingtonpost
Breaking news: FDA, drug firm Biogen ignored internal concerns in approval of Alzheimer’s treatment, House panels say in scathing review https://t.co/lhRBvhUeZh — PolitiTweet.org
Created
Thu Dec 29 19:01:54 +0000 2022
Likes
152
Retweets
52
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The Washington Post @washingtonpost
Breaking news: FDA, drug firm Biogen ignored internal concerns in approval of Alzheimer’s treatment, House panels say in scathing review https://t.co/lhRBvhUeZh — PolitiTweet.org